Delayed Graft Function: Clinical Trials

15 trials for Delayed Graft Function, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated, 2 unknown, 2 withdrawn. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Completed 8, Terminated 3, Unknown 2, Withdrawn 2

Follow Delayed Graft Function: new trials by email Literature Review of Delayed Graft Function trials Research Report on Delayed Graft Function

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen
Mycophenolate Mofetil Capsules - Kidney Transplant Recipients
Phase 4UnknownFirst Affiliated Hospital Xi'an Jiaotong University3002021-01-222022-05-27
Envarsus in Delayed Graft Function (E-DGF)
Envarsus XR, Tacrolimus - Delayed Graft Function
Phase 4CompletedUniversity of Wisconsin, Madison1002019-03-182023-07-20
Cyclosporine A Pretreatment and Kidney Graft Function
cyclosporine A, Placebo - Brain Death, Kidney Transplantation
Phase 4CompletedUniversity Hospital, Clermont-Ferrand6482017-12-192026-08-03
Volatile Anesthetic Protection Of Renal Transplants 2
sevoflurane, propofol - Delayed Graft Function, Renal Outcome After Kidney Transplantation
Phase 4CompletedUniversity Medical Center Groningen4882017-04-012025-07-30
Antegrade Arterial and Portal Flushing Versus Portal Flushing Only in LDLT
Arterial Flushing, Portal Flushing - Biliary Complications, Graft Function, Delayed
Phase 4CompletedInstitute of Liver and Biliary Sciences, India852015-10-012017-06-29
Belatacept in Kidney Transplantation of Moderately Sensitized Patients
Belatacept, Tacrolimus withdrawal, Plasmapheresis/Intravenous Immunoglobulin G - End Stage Renal Disease, Antibody Mediated Rejection
Phase 4WithdrawnUniversity of Wisconsin, Madison2014-09-242018-12-17
ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF
Anti-Thymocyte Globulins treatment, Basiliximab treatment - Kidney Transplantation
Phase 4TerminatedNantes University Hospital192014-06-012017-11-21
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
Belatacept, Tacrolimus, Mycophenolate - Implant or Graft; Rejection
Phase 4CompletedColumbia University572014-06-012021-02-10
Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population
Everolimus - Delayed Function of Renal Transplant
Phase 4UnknownMARIO ABBUD FILHO802012-01-012012-08-13
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Myfortic (mycophenolic acid), Thymoglobulin (anti-thymocyte globulin) - Kidney Transplantation, Renal Transplantation
Phase 4WithdrawnGeorgetown University2010-06-012014-06-09
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
Tacrolimus, Sirolimus - Kidney Transplant, Delayed Graft Function
Phase 4TerminatedUniversity of Maryland, Baltimore322009-04-012022-03-31
Effect of Procrit (Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
Epoetin Alfa - Delayed Graft Function
Phase 4CompletedWest Penn Allegheny Health System762007-02-012010-05-27
PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation
Epoetin beta - Patients Receiving a Kidney From a Non-Heart-Beating Donor
Phase 4CompletedLeiden University Medical Center922005-07-012010-08-02
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
CellCept - Kidney Transplantation, Delayed Graft Function
Phase 4TerminatedMayo Clinic122005-03-012011-12-19
Comparison of Sirolimus and Azathioprine in Lung Transplantation
azathioprine, sirolimus - Delayed Graft Function, Acute Graft Rejection
Phase 4CompletedUniversity of Chicago1812002-04-012016-09-21

Narrower conditions

Brain Death (1)  ·  Kidney Failure, Chronic (1)  ·  Postoperative Complications (1)  ·  Rejection, Psychology (1)  ·  Reperfusion Injury (1)

Broader conditions

Pathologic Processes (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chronic Disease (1)  ·  Coma (1)  ·  Consciousness Disorders (1)  ·  Death (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)

Interventions

Mycophenolic Acid (5)  ·  Antilymphocyte Serum (3)  ·  Tacrolimus (3)  ·  Abatacept (2)  ·  Sirolimus (2)  ·  thymoglobulin (2)  ·  Azathioprine (1)  ·  Cyclosporine (1)  ·  Dexamethasone (1)  ·  Epoetin Alfa (1)  ·  Everolimus (1)  ·  Kidney Transplantation (1)  ·  Methylprednisolone (1)  ·  Neoadjuvant Therapy (1)  ·  Plasmapheresis (1)

Sponsors

University of Wisconsin, Madison (2)  ·  Columbia University (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Georgetown University (1)  ·  Institute of Liver and Biliary Sciences, India (1)  ·  Leiden University Medical Center (1)  ·  MARIO ABBUD FILHO (1)  ·  Mayo Clinic (1)  ·  Nantes University Hospital (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University Medical Center Groningen (1)  ·  University of Chicago (1)  ·  University of Maryland, Baltimore (1)  ·  West Penn Allegheny Health System (1)

Countries

United States (7)  ·  France (2)  ·  Netherlands (2)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  Norway (1)  ·  Spain (1)

Top investigators

Abdolreza Haririan, MD, MPH (1)  ·  Arjang Djamali, M.D. (1)  ·  Edward Garrity, MD (1)  ·  Gertrude J Nieuwenhuijs-Moeke, MD (1)  ·  Joseph K Melancon, MD (1)  ·  Mario Abbud, MD.PhD (1)  ·  Mark A. Hardy, MD (1)  ·  Mark D. Stegall, M.D. (1)  ·  Piyush Kumar Sinha, MS, MCh (1)  ·  Richard J Marcus, MD (1)  ·  Rommel Sandhyav, MS (1)  ·  Sandesh Parajuli, MBBS (1)  ·  Senthil Kumar, MS, FRCS (1)

Results publications

PMID 10580071, PMID 12194926, PMID 12694055, PMID 14961990, PMID 15257455, PMID 17908276, PMID 18336697, PMID 18946341, PMID 19843031, PMID 20814351, PMID 20833822, PMID 21454065, PMID 21454067, PMID 21993970, PMID 22429309, PMID 22745272, PMID 22755430, PMID 22755431, PMID 22959074, PMID 23167441, PMID 23281637, PMID 23370547, PMID 23380861, PMID 24056620, PMID 25545626, PMID 25661873, PMID 26096305, PMID 26099226, PMID 26589470, PMID 26680372, PMID 26965071, PMID 27496434, PMID 29243394, PMID 29334530, PMID 29660004, PMID 29665840, PMID 36791280, PMID 39158946, PMID 40897490, PMID 41504889

NIH funding

2014 (1)